Waiting and watching for the dreaded signs of cancer's return can for some
hold some promise and hope for the future. A two year non return period and
doubling rates can be indicators of progression allowing time frames to be
prepared. Unfortunately Gleason 9 cases slip under the radar as they do not
produce enough PSA to detect it's recurrence until Mets have taken hold. My
Uro told me the 2 year period is not applicable to 9's and the cancer may be
spreading without any PSA reading. What a bonus, living in a complete
vacuum, knowing thay 9's invariably reoccur but having no tieframe yo
associate it with.
Does anyone know of recurrence statistics for 9's, or alternate indicators.
God bless you all
Hank B Schokker Age 55 120 Kg & 183cm Good Health
PSA 2000 / 2003 3.28 7.8 8.7 9.4
Biopsy Oct 02 inconclusive But poss G7
Jun 03 Gleason 8 Staging estimated
at T1
RPP 1 Sep 03 Gleason 4+5=9
Biopsy Extensive adenocarcinoma; Multifaceted;
Extensive perennial invasion
Catheter out 16 Sep 03 and DRY
2nd opinion that a Gleason 9 is virulent and Radiation & HT in
interim is scheduled
EBRT Feb 04 04 to Apr 04
HT Lucron 14 Oct 03 and 16 Mar 04 (lasting 4 months ea)
PSA Jun/04 <00.1
PSA Sept/04 <00.1 and no Testosterone (reading of 1.1)
PSA Dec/04 <00.1 and Testosterone returning (now 12.5 of normal
range of 8:- 27)
PSA Jun 05 still >0.1
David S. - 16 Jun 2005 11:32 GMT
Hank:
What about the "PSA Free" test, does it too fail to indicate what is
going on? Also, I thought I had read somewhere that there is a new third
type of PSA test. Ask about that.
Finally, do they do periodic bone scans? Wouldn't that show if
metastases were taking hold?
I wish you well.
David S.
> Waiting and watching for the dreaded signs of cancer's return can for some
> hold some promise and hope for the future. A two year non return period and
[quoted text clipped - 41 lines]
>
> PSA Jun 05 still >0.1
ron - 16 Jun 2005 14:45 GMT
Hank Schokker wrote...snip...
> Does anyone know of recurrence statistics for 9's, or alternate indicators.
Hi Hank...You might take a look at Walsh's paper (M. Han, A. W. Partin,
M. Zahurak, S. Piantadosi, J. Epstein and P. C. Walsh; J. Urol., 169,
517-523, 2003) where he presents several nomograms that break out
recurrence rates as a function of GS, TNM clinical staging, pre-op PSA
and number of years since surgery. Your projections would presumably
be even better than these since you've had RT in addition to the RP.
The paper can be found on-line at
http://www.prostate-help.org/download/jhnomo.pdf
Best wishes and good health, Ron
Leonard Evens - 16 Jun 2005 23:23 GMT
> Hank Schokker wrote...snip...
>
[quoted text clipped - 9 lines]
>
> http://www.prostate-help.org/download/jhnomo.pdf
Ron,
There seem to be some statistical oddities in the tables in this paper.
I looked at my situation. Before surgery, I was T1c, PSA 4.5, Biopsy
Gleason 7 = 3+4. After surgery, they found the tumor organ confined,
and Surgery Gleason also 7 = 3+4. Yet the after surgery figures were
all slighly smaller than the pre-surgery figures. For example, at 10
years, the presugical prediction was 91 percent but the postsurgical
prediction was 89 percent. This doesn't make much sense because
presumably some cases with a similar presurgical diagnoses would not be
found after surgery to be organ confined.
Of course, sometimes statistical variation occurs because the samples
are different. But if the populations were the same in both cases, it
is hard to see how figures like that could arise.
Do you have any suggestions?
> Best wishes and good health, Ron
ron - 16 Jun 2005 23:58 GMT
Hi Leonard...I think the pre-op and post-op populations are different
in that the post-op, organ-confined population is a mix of T1c and
T2a/b/c. So taking the GS=3+4, PSA=4-10 case, we see that the pre-op
10-year recurrence-free rates are:
T1c 0.91 (Table 2)
T2a 0.88 (Table 3)
T2b/c 0.84 Table 4)
The corresponding post-op, organ-confined number is 0.89 (Table 5) as
you noted. It seems to fit in that it is less than the T1c number and
greater than the T2b/c number...Ron
Leonard Evens - 18 Jun 2005 03:52 GMT
> Hi Leonard...I think the pre-op and post-op populations are different
> in that the post-op, organ-confined population is a mix of T1c and
[quoted text clipped - 7 lines]
> you noted. It seems to fit in that it is less than the T1c number and
> greater than the T2b/c number...Ron
Thanks. Somehow I misread the legends. Of course, you are right.
Also, it seemed paradoxical that my predicted nonrecurrence rate should
be higher based on presurgical information than on the more complete
post surgical information. The response to that would be that adding a
clinical T1c diagnosis to a postsurgical organ confined diagnosis would
presumably raise the nonrecurrence rate higher into the 90s. But since
they didn't bother calculating that, there is no way to know by how
much. It seems implausible to me that it would have much effect.
Stephen Jordan - 16 Jun 2005 21:36 GMT
On June 15, Hank Schokker wrote, in pertinent part:
> Unfortunately Gleason 9 cases slip under
> the radar as they do not produce enough PSA to detect it's (sic)
> recurrence until Mets have taken hold.
Whaaaat!? What is the evidence to support this? Where is the uro getting
his info? Marijuana?
> My Uro told me the 2 year period is not applicable to 9's and the cancer
> may be spreading without any PSA reading.
What two-year period is that? The American Society of Clinical Oncology
has established this guideline for judging whether the PCa has recurred:
Three consecutive rises in *PSA* There is no differentiation set for those
of us with high-Gleason tumors. FYI, my known tumor (there was another)
was a Gleason 4+5=9 in mid-2003. The other one, not found by the first
biopsy, was a Gleason 4+4=8.
Hank should check the Partin Tables. Partin, BTW, was/is a senior medic at
the Brady Urological Institute, Johns Hopkins. The table can be found at:
http://urology.jhu.edu/prostate/partintables.php
For me, the numbers were, though not wonderful, encouraging.
Another nomogram is the Memorial Sloan-Kettering. I don't have the URL
handy, but it can be found by Hank if he's interested.
With my Gleason 9 and other figures entered, MSK's nomogram calculated
my *five-year recurrence-free probability at 80%*
BTW, my uro did not compute these nomograms, nor even give evidence
that he knew of their existence. I found them and did the calculations. I
also fired the uro. I have also fired a radiation oncologist who was
ignorant
of certain basic facts about PCa.
I think I see a hint of the cause of Hank's anxiety: he's getting bum advice
from a urologist -- one who, it seems, might be a fine surgeon, but not so
good an oncologist. I strongly recommend three actions:
1. Check the nomograms
2. Consult the website of the Prostate Cancer Research Institute at:
http://prostate-cancer.org/index.html
There, he will find unbiased and authoritative information.
3. Fire the uro and consult a medical oncologist -- one who is
well-experienced with PCa.
Regards,
Steve J
"'MD' does not mean 'Medical Deity.'"
-- Stephen B. Strum, MD
Steve Kramer - 17 Jun 2005 02:40 GMT
I have no stats, Hank, but congrats on the PSA.

Signature
PSA 16 10/17/2000 @ 46
Biopsy 11/01/2000 G7 (3+4), T2c
RRP 12/15/2000 G7 (3+4), T3cN0M0 Neg margins
PSA .1 .1 .1 .27 .37 .75
EBRT 05-07/2002 @ 47
PSA .34 .22 .15 .21 .32
Lupron 07/03 (1 mo) 8/03 (4 mo), 12/03, 4/04, 09/04, 01/05
PSA .07 .05 .06 .05
non Illegitimi carborundum
> Waiting and watching for the dreaded signs of cancer's return can for some
> hold some promise and hope for the future. A two year non return period and
[quoted text clipped - 41 lines]
>
> PSA Jun 05 still >0.1